517 related articles for article (PubMed ID: 6203206)
21. [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers].
Yamaguchi K; Tanaka M; Kitagawa N; Kotake T; Yanagi S; Ito H
Hinyokika Kiyo; 1989 Jun; 35(6):987-91. PubMed ID: 2478006
[TBL] [Abstract][Full Text] [Related]
22. [Determination of acid phosphatase in prostatic carcinoma].
Bauer HW; Walther V; Schmiedt F
Fortschr Med; 1980 Sep; 98(34):1301-5. PubMed ID: 7461538
[TBL] [Abstract][Full Text] [Related]
23. Prostate specific acid phosphatase versus five other possible tumour markers: a comparative study in men with prostatic carcinoma.
Larson A; Fritjofsson A; Norlén BJ; Gronowitz JS; Ronquist G
Scand J Clin Lab Invest Suppl; 1985; 179():81-8. PubMed ID: 2417306
[No Abstract] [Full Text] [Related]
24. Immunohistochemistry in the diagnosis of difficult cases of prostatic cancer.
Caillaud JM; Mathieu MC; Carlu C
Prog Clin Biol Res; 1987; 243A():477-83. PubMed ID: 2443919
[No Abstract] [Full Text] [Related]
25. [Immunologic sperm detection].
Müller V; Hinkelmann G
Arch Kriminol; 1991; 188(3-4):106-9. PubMed ID: 1722088
[TBL] [Abstract][Full Text] [Related]
26. Prostatic acid phosphatase: current concepts.
Romas NA
Semin Urol; 1983 Aug; 1(3):177-85. PubMed ID: 6379804
[TBL] [Abstract][Full Text] [Related]
27. Comparison of prostatic acid phosphatase assays.
Wise WS; Kandaswamy K
Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
[TBL] [Abstract][Full Text] [Related]
28. Clinical application of prostatic markers. I. Classification of prostatic tumours using immunohistochemical techniques.
Svanholm H; Hørder M
Scand J Urol Nephrol Suppl; 1988; 107():65-70. PubMed ID: 2453920
[TBL] [Abstract][Full Text] [Related]
29. [Reliability and use of prostate-specific antigen in the management of patients with prostatic cancer].
Hübler J; Jávor A
Orv Hetil; 1993 Jul; 134(28):1529-32. PubMed ID: 7688112
[TBL] [Abstract][Full Text] [Related]
30. [New prospective diagnostic serum markers in prostatic cancer].
Mirone V; De Bellis G; Prezioso D; Sanseverino R; Iannucci F; Padulano P
Minerva Med; 1986 Mar; 77(13):503-4. PubMed ID: 2422605
[No Abstract] [Full Text] [Related]
31. [Immunohistochemical determination of prostate-specific acid phosphatase (PSAP), prostate-specific antigen (PSA) and epithelial membrane antigen (EMA) with monoclonal antibodies in punch biopsies of the prostate].
Wacker U; Müller HA
Verh Dtsch Ges Pathol; 1986; 70():325-8. PubMed ID: 2435081
[No Abstract] [Full Text] [Related]
32. A solid-phase radioimmunoassay for human prostatic acid phosphatase.
Foti AG; Herschman H; Cooper JF
Cancer Res; 1975 Sep; 35(9):2446-52. PubMed ID: 1170944
[TBL] [Abstract][Full Text] [Related]
33. [Prostatic acid phosphatase and prostatic specific antigen measured by immunoenzyme assay].
Fuse H; Akimoto S; Shimazaki J
Hinyokika Kiyo; 1986 Dec; 32(12):1813-9. PubMed ID: 2435130
[TBL] [Abstract][Full Text] [Related]
34. [Prostate-specific antigen: contribution of monoclonal antibodies to its plasma determination by radioimmunoassay].
Gutiérrez Mínguez E; García Talavera JR; Martín Rodríguez M; Sánchez González ML; Díaz Alférez FJ; Urrutia Avisrror M
Arch Esp Urol; 1988 Apr; 41(3):188-92. PubMed ID: 2456746
[No Abstract] [Full Text] [Related]
35. Critical-laboratoristic correlation of the diagnostic importance of prostate specific antigen compared with prostatic acid phosphatase and carcinoembryonic antigen in the prostatic cancer.
Milani M; Tacconi R; Marsili G; Trognoni A; Centioni G; Leoni T; Fumarola A
Quad Sclavo Diagn; 1986 Dec; 22(4):428-32. PubMed ID: 2445000
[No Abstract] [Full Text] [Related]
36. Economics of screening for carcinoma of the prostate.
Optenberg SA; Thompson IM
Urol Clin North Am; 1990 Nov; 17(4):719-37. PubMed ID: 1699340
[TBL] [Abstract][Full Text] [Related]
37. An evaluation of five tests to diagnose prostate cancer.
Guinan P; Ray P; Bhatti R; Rubenstein M
Prog Clin Biol Res; 1987; 243A():551-8. PubMed ID: 2443922
[TBL] [Abstract][Full Text] [Related]
38. Serum prostatic acid phosphatase (PAP): monoclonal enzyme-linked immunoassay compared to polyclonal radioimmunoassay.
Taylor EH; Gadsden RH
Ann Clin Lab Sci; 1984; 14(1):21-6. PubMed ID: 6364952
[TBL] [Abstract][Full Text] [Related]
39. [Prostatic specific antigen in the serum in prostatic cancer].
Fuse H; Akakura K; Akimoto S; Shimazaki J
Hinyokika Kiyo; 1987 Jul; 33(7):1049-53. PubMed ID: 2446484
[TBL] [Abstract][Full Text] [Related]
40. Ratio of polyclonal-monoclonal prostate-specific antigen levels. Discrimination of nodal status in prostate tumors that produce low marker levels.
Stephenson RA; Greskovich FJ; Fritsche HA; James BC
Urol Clin North Am; 1991 Aug; 18(3):467-71. PubMed ID: 1715103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
